Baudax Bio (NASDAQ:BXRX) reported its Q4 earnings results on Wednesday, March 16, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Baudax Bio reported an EPS of $-4.41.
Revenue was up $324.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.75 which was followed by a 0.36% increase in the share price the next day.
Here's a look at Baudax Bio's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -5.25 | -7 | -6.65 | -21.35 |
| EPS Actual | -7 | -7.35 | -9.45 | -3.15 |
| Revenue Estimate | 600.00K | 470.00K | 630.00K | 1.63M |
| Revenue Actual | 281.00K | 201.00K | 198.00K | 76.00K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
